Cefazolin in Dextrose recall
FDA recall D-0787-2026 · initiated Jul 24, 2026
Baxter Healthcare Corporation recalled Cefazolin in Dextrose in Jul 2026 — an FDA Class I recall (D-0787-2026) because Presence of Particulate Matter.
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Presence of Particulate Matter
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 19,032 bags
Details
- Product
- Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
- Recalling company
- Baxter Healthcare Corporation
- Classification
- Class I
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Jul 24, 2026
- FDA report date
- Aug 19, 2026
Frequently asked
- Was Cefazolin in Dextrose recalled?
- Baxter Healthcare Corporation recalled Cefazolin in Dextrose in Jul 2026 — an FDA Class I recall (D-0787-2026) because Presence of Particulate Matter. Most serious — a reasonable probability that use will cause serious harm or death.
- Why was Cefazolin in Dextrose recalled?
- Per the FDA enforcement record, the reason for recall D-0787-2026 was: Presence of Particulate Matter
- Is a recalled Cefazolin in Dextrose dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Cefazolin in Dextrose are affected?
- Distributed: US Nationwide.. The recall covers these lots — Lot # LD175708, Exp Date: 14-Feb-2027.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0787-2026.